Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Flecainide for PVC Suppression and Blood Pressure Control
NCT01833455Phase 2Terminated
- Sponsor
- University of Wisconsin–Madison
- Start
- Feb 2013
- Primary completion
- Jun 2016
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of flecainide in premature ventricular contraction (PVC), sponsored by University of Wisconsin–Madison. Started Feb 2013; status: terminated.
02
Drugs
flecainide
03
Conditions
premature ventricular contraction (PVC)
Beyond the preview
Go deeper on NCT01833455.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01833455.